1. Define, compare and contrast the five main models of biorepository services: procurement service, banking service, population-based collections, disease-based collections, and virtual repository. Describe the role of each in supporting research efforts.
2. Define the following pre-analytical variables for surgically removed tissue biospecimens:
Biospecimen’s warm ischemia time
Biospecimen’s cold ischemia time
3. List 5 biorepository stakeholders.
4. Define the following terms as related to biospecimens or donor information.
Coded
De-identified
Anonymized
Anonymous
5. A pathologist (or designee) determines that there is suficient tissue for diagnosis before providing remnant (left-over) tissue for biobanking. However, many institutions have and additional requirement for an “embargo period “ for the banked remnant tissue. Explain what the “embargo period” is and how this policy minimizes the risk of harm to biorepository participants.